{
    "clinical_study": {
        "@rank": "109132", 
        "arm_group": {
            "arm_group_label": "WA- NG Telescope Prothesis", 
            "arm_group_type": "Experimental", 
            "description": "Implantable Miniature Telescope for end stage AMD"
        }, 
        "brief_summary": {
            "textblock": "This is a pilot study to evaluate the safety of the Model WA-NG telescope prosthesis in\n      patients with bilateral moderate to profound central vision impairment due to end-stage\n      age-related macular degeneration."
        }, 
        "brief_title": "Study of WA-NG Telescope Prosthesis in Patients With End-stage Age-related Macular Degeneration", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Age Related Macular Degeneration", 
        "condition_browse": {
            "mesh_term": "Macular Degeneration"
        }, 
        "detailed_description": {
            "textblock": "Patients will be screened for eligibility and informed consent will be obtained from those\n      who meet screening criteria and are interested in participating in the study. Eligible\n      patients will be examined preoperatively to obtain a medical history and to establish a\n      baseline for ocular condition. Baseline measurements will include successful use of an\n      external telescope.\n\n      Postoperatively, patients will undergo ophthalmic evaluation at regular intervals as\n      specified in this protocol and will be required to return for 6 to 10 additional visits for\n      vision training with a low vision specialist."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Bi-lateral, stable, moderate to profound (20/80 to 20/800) central vision impairment due\n        to bilateral scotoma associated with end-stage macular degeneration, defined as retinal\n        finds of bilateral, geographic atrophy or disciform scar with foveal involvment.  Phakic\n        in the operative eye.  Must achieve a 5 letter improved with external telescope simulator.\n\n        Exclusion Criteria:\n\n        Evidence of active CNV or any ophthalmic pathology that compromises peripheral vision of\n        fellow eye or predisposes eye rubbing.  Previous intraocular of corneal surgery of any\n        kind in operative eye.  Retinal disease, optic nerve disease, diabetic retinopathy,\n        retinal tears, or any introcular tumor or medical or ophthalmic condition that in the\n        opinion of the investigator renders the subject unsuitable for participation."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "65 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01731964", 
            "org_study_id": "WA-NG-001 ASSAF HAROFEH"
        }, 
        "intervention": [
            {
                "arm_group_label": "WA- NG Telescope Prothesis", 
                "description": "Monocular implantation of the telescope prosthesis after cataract extraction", 
                "intervention_name": "Telescope prosthesis", 
                "intervention_type": "Device", 
                "other_name": "IMT-NG"
            }, 
            {
                "arm_group_label": "WA- NG Telescope Prothesis", 
                "description": "The WA-NG telescope prosthesis (Figure 1) is the next generation telescopic implantable device which, when combined with the optics of the cornea, constitutes a telephoto system for improvement of visual acuity in patients with severe to profound vision impairment due to bilateral, end-stage age-related macular degeneration. The device is implanted in one of the patient's eyes. In this way, the implanted eye provides central vision and the non-implanted eye can continue to provide peripheral vision.", 
                "intervention_name": "WA-NG Telescope Prothesis", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Macular Degeneration", 
            "Visual Impairment", 
            "Implantable Telescope"
        ], 
        "lastchanged_date": "April 30, 2014", 
        "location": {
            "contact": {
                "email": "IzakA@asaf.health.gov.il", 
                "last_name": "Isaac Avni, MD", 
                "phone": "+972-8-9779358"
            }, 
            "contact_backup": {
                "email": "assaf.research@gmail.com", 
                "last_name": "Ella Shvalov", 
                "phone": "972-8-9204240"
            }, 
            "facility": {
                "address": {
                    "city": "Zerifin", 
                    "country": "Israel", 
                    "zip": "70300"
                }, 
                "name": "Assaf Harofeh Medical Center"
            }, 
            "investigator": {
                "last_name": "Isaac Avni, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "Pilot Study of WA-NG Telescope Prosthesis in Patients With Central Vision Impairment Associated With End-stage Age-related Macular Degeneration", 
        "overall_official": {
            "affiliation": "Assaf-Harofeh Medical Center", 
            "last_name": "Isaac Avni, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Positional stability assessed by slit lamp examination and anterior segment OCT", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01731964"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "adverse events", 
            "measure": "Safety", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "source": "VisionCare Ophthalmic Technologies, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "VisionCare Ophthalmic Technologies, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}